Cargando…
TMPRSS2: Potential Biomarker for COVID‐19 Outcomes
Autores principales: | Strope, Jonathan D., PharmD, Cindy H. Chau, Figg, William D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7280622/ https://www.ncbi.nlm.nih.gov/pubmed/32437018 http://dx.doi.org/10.1002/jcph.1641 |
Ejemplares similares
-
Are sex discordant outcomes in COVID-19 related to sex hormones?
por: Strope, Jonathan D., et al.
Publicado: (2020) -
SUN-117 Growth Hormone-Releasing Hormone (GHRH) Deficiency Promotes Inflammation Associated Carcinogenesis
por: Recinella, PharmD, Lucia, et al.
Publicado: (2020) -
SAT-603 Growth Hormone-Releasing Hormone (GHRH) Antagonists Stimulate Feeding in Mice
por: Leone, Sheila, et al.
Publicado: (2020) -
Down syndrome: the aggravation of COVID-19 may be partially justified by the expression of TMPRSS2
por: Evangelho, Victor Gustavo Oliveira, et al.
Publicado: (2021) -
Delayed presentation and sub-optimal outcomes of pediatric patients with acute appendicitis during the COVID-19 pandemic
por: Gerall, Claire D., et al.
Publicado: (2021)